Y-Intercept (HK)’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,697
Closed -$16K 1380
2022
Q2
$16K Buy
+10,697
New +$7.86K ﹤0.01% 799

Other funds holding EPZM

Y-Intercept (HK)'s EPZM Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 10,697 shares — an estimated $16K sold.

Y-Intercept (HK) first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $16K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • Y-Intercept (HK) reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 10,697 Epizyme, Inc shares in Q3 2022, an estimated $16K.
  • Y-Intercept (HK) first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s Epizyme, Inc position peaked at $16K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.